Carregant...

Selisistat, a SIRT1 inhibitor, enhances paclitaxel activity in luminal and triple-negative breast cancer: in silico, in vitro, and in vivo studies

Sirtuins (SIRTs) are NAD+-dependent histone deacetylases, which play a key role in cancer progression; however, their prognostic values in breast cancer (BC) remain a subject of debate and controversy. Accumulative evidence suggests that each sirtuin possesses individual character, implicating its r...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Anna Wawruszak, Jarogniew Luszczki, Damian Bartuzi, Joanna Kalafut, Estera Okon, Arkadiusz Czerwonka, Andrzej Stepulak
Format: Artigo
Idioma:Inglês
Publicat: Taylor & Francis Group 2025-12-01
Col·lecció:Journal of Enzyme Inhibition and Medicinal Chemistry
Matèries:
Accés en línia:https://www.tandfonline.com/doi/10.1080/14756366.2025.2458554
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!